Page last updated: 2024-08-16

propranolol and doxazosin

propranolol has been researched along with doxazosin in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19904 (17.39)18.7374
1990's5 (21.74)18.2507
2000's9 (39.13)29.6817
2010's3 (13.04)24.3611
2020's2 (8.70)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Colagrande, F; Jackman, GP; Louis, WJ1
Elsegood, CL; Mackintosh, VS; Redgrave, TG1
Jansen, H1
Baggen, RG; Jansen, H1
Ontko, JA; Woodside, WF1
Baggen, MG; Birkenhäger, JC; Jansen, H; Lammers, R1
Jie, K; Timmermans, PB; van Brummelen, P; van Zwieten, PA; Vermey, P1
Birkeland, S; Brunvand, H; Grong, K; Hexeberg, E; Rynning, SE1
Berge, RK; Brunvand, H; Grong, K; Kvitting, PM; Rynning, SE1
Borea, PA; Caiazza, A; Gessi, S; Manfredini, R; Portaluppi, F; Varani, K1
Aizawa, Y; Chinushi, M; Furushima, H; Washizuka, T1
Borea, PA; Cattabriga, E; Iannotta, V; Manfredini, R; Pancaldi, C; Portaluppi, F; Uluoglu, C; Varani, K1
Busca, G; Clari, F; Facoetti, A; Fallarini, S; Ferrari, AU; Ferrero, I; Fogari, R; Nano, R; Palladini, G; Perlini, S; Tozzi, R1
Busca, G; Cesana, F; Clari, F; Ferrari, AU; Ferrero, I; Gatti, C; Janetti, MB; Mancia, G; Palladini, G; Perlini, S; Tozzi, R; Vezzoli, M1
Cadirci, E; Gocer, F; Hacimuftuoglu, A; Halici, Z; Keles, S; Suleyman, H1
Abzalov, NI; Abzalov, RA; Gulyakov, AA; Nikitin, AS; Vafina, EZ1
Angele, P; El Bagdadi, K; Grässel, S; Hedderich, J; Jenei-Lanzl, Z; Meurer, A; Straub, RH; Zaucke, F1

Reviews

1 review(s) available for propranolol and doxazosin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

3 trial(s) available for propranolol and doxazosin

ArticleYear
Vascular alpha-adrenoceptors in man: interactions with adrenaline and noradrenaline.
    Clinical science (London, England : 1979), 1985, Volume: 68 Suppl 10

    Topics: Adult; Doxazosin; Epinephrine; Forearm; Humans; Male; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Vasoconstriction; Yohimbine

1985
Role of alpha1-blockade in congenital long QT syndrome: investigation by exercise stress test.
    Japanese circulation journal, 2001, Volume: 65, Issue:7

    Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Doxazosin; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Propranolol

2001
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:6

    Topics: Adenosine-5'-(N-ethylcarboxamide); Adult; Antihypertensive Agents; Binding, Competitive; Blood Pressure; Body Mass Index; Cyclic AMP; Diastole; Doxazosin; Female; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Neutrophils; Propranolol; Radioligand Assay; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reference Values; Systole; Treatment Outcome; Triazines; Triazoles

2002

Other Studies

19 other study(ies) available for propranolol and doxazosin

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Validation of a solid-phase extraction high-performance liquid chromatographic assay for doxazosin.
    Journal of chromatography, 1991, May-03, Volume: 566, Issue:1

    Topics: Adrenergic alpha-Antagonists; Chromatography, High Pressure Liquid; Doxazosin; Humans; Hydrogen-Ion Concentration; Methanol; Prazosin; Propranolol

1991
Effects of adrenoreceptor antagonists and agonists on clearance of emulsion models of triacylglycerol-rich lipoproteins from plasma in rats.
    Clinical and experimental pharmacology & physiology, 1991, Volume: 18, Issue:11

    Topics: Adrenergic Agonists; Adrenergic alpha-Antagonists; Adrenergic Antagonists; Angiotensin II; Animals; Cholesterol Esters; Doxazosin; Emulsions; Fenoterol; Isoproterenol; Lipoprotein Lipase; Lipoproteins; Male; Norepinephrine; Phenylephrine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Rats, Inbred WKY; Receptors, Adrenergic; Triglycerides

1991
The mode of action of alpha 1-adrenoceptor blockers on blood lipids.
    Journal of human hypertension, 1990, Volume: 4 Suppl 3

    Topics: Animals; Atenolol; Cholesterol, Dietary; Cholesterol, HDL; Cricetinae; Doxazosin; Humans; Lipoprotein Lipase; Mesocricetus; Prazosin; Propranolol; Time Factors; Triglycerides

1990
Effects of doxazosin and propranolol administration on lipoprotein lipases in cholesterol-fed rats.
    Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 9

    Topics: Adipose Tissue; Adrenergic alpha-Antagonists; Animals; Cholesterol, Dietary; Doxazosin; Insulin; Lipids; Lipoprotein Lipase; Liver; Male; Myocardium; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Thyroid Hormones

1987
Regulation of triglyceride mobilization in isolated hepatocytes by dibutyryl cyclic AMP and epinephrine.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Animals; Bucladesine; Chloroquine; Doxazosin; Epinephrine; Epoxy Compounds; Fatty Acids; Lipid Mobilization; Liver; Male; Prazosin; Propranolol; Rats; Triglycerides

1989
Effects of doxazosin on lipids, lipoprotein lipases, and cholesterol synthesis in the golden hamster.
    Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 2

    Topics: Adrenergic alpha-Antagonists; Animals; Atenolol; Cholesterol; Cholesterol, Dietary; Cricetinae; Doxazosin; Insulin; Lipase; Lipoprotein Lipase; Liver; Male; Mesocricetus; Norepinephrine; Prazosin; Propranolol; Thyroid Hormones; Triglycerides

1989
Endogenous adenosine attenuates myocardial stunning by antiadrenergic effects exerted during ischemia and not during reperfusion.
    Journal of cardiovascular pharmacology, 1995, Volume: 25, Issue:3

    Topics: Adenosine; Animals; Cats; Coronary Circulation; Doxazosin; Heart; Hemodynamics; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Propranolol; Purinergic P1 Receptor Antagonists; Sympathetic Nervous System; Theophylline

1995
Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms.
    Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:3

    Topics: Adrenergic Antagonists; Animals; Carbazoles; Carvedilol; Cats; Doxazosin; Free Radical Scavengers; Glutathione; Heart; Hemodynamics; Male; Myocardial Reperfusion Injury; Myocardium; Propanolamines; Propranolol; Thiobarbituric Acid Reactive Substances

1996
Platelet alpha2-adrenoceptor alterations in patients with essential hypertension are normalized after treatment with doxazosin but not propranolol.
    Journal of hypertension, 2000, Volume: 18, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Platelets; Brimonidine Tartrate; Case-Control Studies; Cell Membrane; Doxazosin; Female; Humans; Hypertension; In Vitro Techniques; Kinetics; Male; Middle Aged; Propranolol; Quinoxalines; Receptors, Adrenergic, alpha-2

2000
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 46, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiomegaly; Collagen; Doxazosin; Fibrosis; Hypertension; Lung; Male; Matrix Metalloproteinase 2; Myocardium; Propranolol; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Tissue Inhibitor of Metalloproteinase-2

2005
Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta, Abdominal; Blood Pressure; Doxazosin; Heart Failure; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; Oxidopamine; Propranolol; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical

2006
Indirect role of alpha2-adrenoreceptors in anti-ulcer effect mechanism of nimesulide in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2007, Volume: 375, Issue:3

    Topics: Adrenalectomy; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; alpha-Methyltyrosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Corticosterone; Desoxycorticosterone; Dose-Response Relationship, Drug; Doxazosin; Epinephrine; Indomethacin; Male; Metyrapone; Prednisolone; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Stomach Ulcer; Sulfonamides; Yohimbine

2007
Regulation of pumping function of the heart in developing body under changing regimens of motor activity.
    Bulletin of experimental biology and medicine, 2014, Volume: 157, Issue:2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cardiac Output; Doxazosin; Heart; Hypokinesia; Propranolol; Rats; Stroke Volume

2014
Norepinephrine Inhibits the Proliferation of
    International journal of molecular sciences, 2020, May-30, Volume: 21, Issue:11

    Topics: Adult; Aged; Bone Marrow Cells; Cell Proliferation; Cell Survival; Cells, Cultured; Chondrocytes; Cyclic AMP-Dependent Protein Kinases; Doxazosin; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Profiling; Humans; Male; MAP Kinase Signaling System; Mesenchymal Stem Cells; Middle Aged; Neurotransmitter Agents; Norepinephrine; Phosphorylation; Propranolol; Receptors, Adrenergic, beta-2; Signal Transduction; Yohimbine; Young Adult

2020